Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Galinsky

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2009
Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in ratsXin Zhang, Raymond E Galinsky, Robert E Kimura, et al.
Journal of Toxicology. Clinical Toxicology|March 1, 1982
Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophenS M Pond, T G Tong, G A Kaysen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 15, 2008
Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in ratsSara K Quinney, Raymond E Galinsky, Vanida A Jiyamapa-Serna, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
The effect of anesthesia and surgery on CYP3A activity in ratsMichael R Uhing, David W A Beno, Vanida A Jiyamapa-Serna, et al.
Veterinary Therapeutics : Research in Applied Veterinary Medicine|July 4, 2008
Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogsLisa A Abbo, Jeff C H Ko, Lara K Maxwell, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2016
Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy VolunteersZeruesenay Desta, Ingrid F Metzger, Nancy Thong, et al.
Journal of Pharmaceutical Sciences|October 16, 2024
Changes in drug crystallinity in a commercial tacrolimus amorphous formulation result in variable pharmacokineticsLynne S Taylor, Niraj S Trasi, Hitesh S Purohit, et al.
Endocrinology|July 9, 2010
Differential effects of insufflated, subcutaneous, and intravenous growth hormone on bone growth, cognitive function, and NMDA receptor subunit expressionSung Won Park, Sooyoung Shin, Chi Hwa Kim, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2009
Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in ratsXin Zhang, Raymond E Galinsky, Robert E Kimura, et al.
Journal of Toxicology. Clinical Toxicology|March 1, 1982
Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophenS M Pond, T G Tong, G A Kaysen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 15, 2008
Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in ratsSara K Quinney, Raymond E Galinsky, Vanida A Jiyamapa-Serna, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
The effect of anesthesia and surgery on CYP3A activity in ratsMichael R Uhing, David W A Beno, Vanida A Jiyamapa-Serna, et al.
Veterinary Therapeutics : Research in Applied Veterinary Medicine|July 4, 2008
Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogsLisa A Abbo, Jeff C H Ko, Lara K Maxwell, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2016
Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy VolunteersZeruesenay Desta, Ingrid F Metzger, Nancy Thong, et al.
Journal of Pharmaceutical Sciences|October 16, 2024
Changes in drug crystallinity in a commercial tacrolimus amorphous formulation result in variable pharmacokineticsLynne S Taylor, Niraj S Trasi, Hitesh S Purohit, et al.
Endocrinology|July 9, 2010
Differential effects of insufflated, subcutaneous, and intravenous growth hormone on bone growth, cognitive function, and NMDA receptor subunit expressionSung Won Park, Sooyoung Shin, Chi Hwa Kim, et al.
Pageof 5